Navigating Non-Diagnostic Peripheral Lung Lesion Biopsies

Percutaneous transthoracic needle biopsy remains a cornerstone for diagnosing chest pathology, but non-diagnostic outcomes occur frequently. Therefore, clinicians must carefully evaluate patients undergoing a peripheral lung lesion biopsy when initial tissue sampling fails to yield a definitive result. Consequently, understanding underlying risk factors helps physicians determine whether re-biopsy or surgical resection is necessary. Moreover, advanced imaging techniques offer valuable solutions to overcome diagnostic sampling challenges.

Understanding Malignancy Risk in Peripheral Lung Lesion Biopsy

Recent multicenter clinical evidence shows that non-diagnostic biopsy results happen in nearly 40% of peripheral pulmonary lesions. However, a non-diagnostic finding does not rule out malignant disease. In fact, large lesion size significantly correlates with an elevated risk of cancer. Additionally, specific imaging features such as necrotic centers and irregular margins increase the likelihood of malignancy. Therefore, clinicians should not assume that nonspecific benign findings or insufficient tissue represent true benign disease. Instead, careful multidisciplinary review is essential for guiding subsequent diagnostic steps.

The Clinical Efficacy of Contrast-Enhanced Ultrasound

Conventional B-mode ultrasound sometimes fails to differentiate viable tumor tissue from internal necrosis or atelectasis. Consequently, needle placement into necrotic areas yields inadequate cellularity or non-diagnostic samples. To solve this problem, contrast-enhanced ultrasound (CEUS) provides real-time microvascular perfusion imaging of subpleural lesions. Specifically, CEUS highlights vascularized active tumor zones while clearly identifying avascular necrotic regions. As a result, interventionalists can precisely target viable tissue during repeated procedures. Furthermore, utilizing CEUS significantly reduces non-diagnostic rates and improves overall sampling accuracy. Ultimately, incorporating contrast guidance enhances diagnostic confidence and minimizes unnecessary repeat interventions.

Frequently Asked Questions

Q1: Why do non-diagnostic results occur during a peripheral lung lesion biopsy?

Non-diagnostic results often occur because the biopsy needle samples necrotic tissue, fibrosis, or surrounding atelectasis rather than viable tumor cells.

Q2: How does contrast-enhanced ultrasound improve biopsy success?

Contrast-enhanced ultrasound delineates active vascularized areas from avascular necrotic cores, allowing clinicians to target viable tissue accurately.

Q3: Should patients with non-diagnostic biopsy results undergo follow-up or re-biopsy?

Because non-diagnostic lesions carry a substantial risk of malignancy, clinicians typically recommend repeat biopsy with advanced guidance or surgical intervention.

References

1. Li Q et al. Malignancy risk and contrast-enhanced ultrasound guidance in non-diagnostic biopsies of peripheral lung lesions: a multicenter study. Eur Radiol. 2026 Jul 29. doi: 10.1007/s00330-026-12763-6. PMID: 42525281.
2. Wang XY et al. Contrast-enhanced Imaging in Peripheral Pulmonary Lesions: The Role in US-guided Biopsies. Radiology: Cardiothoracic Imaging. 2024 Jun;6(3):e230234.